RhumbLine Advisers’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $127K | Sell |
|
|||||
|
2024
Q4 | $180K | Buy |
|
|||||
|
2024
Q3 | $378K | Buy |
|
|||||
|
2024
Q2 | $378K | Sell |
|
|||||
|
2024
Q1 | $620K | Buy |
|
|||||
|
2023
Q4 | $526K | Buy |
|
|||||
|
2023
Q3 | $395K | Sell |
|
|||||
|
2023
Q2 | $874K | Buy |
|
|||||
|
2023
Q1 | $642K | Buy |
|
|||||
|
2022
Q4 | $913K | Sell |
|
|||||
|
2022
Q3 | $1.96M | Buy |
|
|||||
|
2022
Q2 | $1.63M | Buy |
|
|||||
|
2022
Q1 | $764K | Buy |
|
|||||
|
2021
Q4 | $180K | Buy |
|
|||||
|
2021
Q3 | $250K | Buy |
|